Microribonucleic acids and gastric cancer

Cancer Science

Volumn 103, Issue 4, 2012, Pages 620-625

  Ma, Ying Yu ^a   Tao, Hou Quan ^a  

^a Key Laboratory of Gastroenterology of Zhejiang Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MICRORNA; MICRORNA 126; MICRORNA 181C; MICRORNA 21; MICRORNA 432AS; MICRORNA 449; PROTEIN P21; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CIRCULATING TUMOR CELL; CYTOKINE RELEASE; DISEASE ASSOCIATION; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC REGULATION; HELICOBACTER INFECTION; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; RNA PROCESSING; RNA SYNTHESIS; STOMACH CARCINOGENESIS; UPREGULATION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; ONCOGENES; PROGNOSIS; RNA, SMALL UNTRANSLATED; STOMACH NEOPLASMS;

EID: 84862796154     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02185.x     Document Type: Review

References (74)

1. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366: 1784-93.
2. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-64.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54.
4. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-33.
5. Johnson SM, Grosshans H, Shingara Jet al.RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-47.
6. Rosenfeld N, Aharonov R, Meiri Eet al.MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008; 26: 462-9.
7. Alajez NM, Lenarduzzi M, Ito Eet al.MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011; 71: 2381-91.
8. Kim YK, Yu J, Han TSet al.Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-81.
9. Lal A, Kim HH, Abdelmohsen Ket al.p16(INK4a) translation suppressed by miR-24. PLoS ONE 2008; 3: e1864.
10. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.
11. Saito Y, Suzuki H, Tsugawa Het al.Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 2009; 28: 2738-44.
12. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 2010; 9: 16.
13. Zhang H, Li Y, Huang Qet al.MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 2011; 18: 1702-10.
14. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
15. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009; 4: 199-227.
16. Volinia S, Calin GA, Liu CGet al.A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61.
17. Guo J, Miao Y, Xiao Bet al.Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009; 24: 652-7.
18. Zhang Z, Li Z, Gao Cet al.miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88: 1358-66.
19. Fujita S, Ito T, Mizutani Tet al.miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 2008; 378: 492-504.
20. Liu Z, Xiao B, Tang Bet al.Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect 2010; 12: 854-63.
21. Xiao B, Liu Z, Li BSet al.Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009; 200: 916-25.
22. Loffler D, Brocke-Heidrich K, Pfeifer Get al.Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 2007; 110: 1330-3.
23. Shin VY, Jin H, Ng EKet al.NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 2011; 32: 240-5.
24. Motoyama K, Inoue H, Mimori Ket al.Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 2010; 36: 1089-95.
25. Chan SH, Wu CW, Li AF, Chi CW, Lin WC. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008; 28: 907-11.
26. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328-36.
27. Zhang L, Volinia S, Bonome Tet al.Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008; 105: 7004-9.
28. Jin Z, Selaru FM, Cheng Yet al.MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 2011; 30: 1577-85.
29. Xiao B, Guo J, Miao Yet al.Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 2009; 400: 97-102.
30. Cascio S, D'Andrea A, Ferla Ret al.miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 2010; 224: 242-9.
31. Fan X, Liu Y, Jiang Jet al.miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 2010; 42: 318-24.
32. Jiang Z, Guo J, Xiao Bet al.Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010; 45: 17-23.
33. Liu M, Wang Z, Yang Set al.TNF-alpha is a novel target of miR-19a. Int J Oncol 2011; 38: 1013-22.
34. Hayashita Y, Osada H, Tatematsu Yet al.A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-32.
35. Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007; 67: 5699-707.
36. Petrocca F, Visone R, Onelli MRet al.E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-86.
37. Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 2010; 31: 777-84.
38. Zhu W, Shan X, Wang T, Shu Y, Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010; 127: 2520-9.
39. Godlewski J, Bronisz A, Nowicki MO, Chiocca EA, Lawler S. microRNA-451: a conditional switch controlling glioma cell proliferation and migration. Cell Cycle 2010; 9: 2742-8.
40. Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011; 30: 2644-58.
41. Bandres E, Bitarte N, Arias Fet al.microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009; 15: 2281-90.
42. Wang HJ, Ruan HJ, He XJet al.MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 2010; 46: 2295-303.
43. Yang Q, Jie Z, Cao Het al.Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 2011; 32: 713-22.
44. Oh HK, Tan AL, Das Ket al.Genomic loss of miR-486 regulates tumor progression and the OLFM4 anti-apoptotic factor in gastric cancer. Clin Cancer Res 2011; 17: 2657-67.
45. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen Aet al.miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29.
46. Li X, Zhang Y, Shi Yet al.MicroRNA-107, an oncogene MicroRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer: MiR-107 promotes gastric cancer invasion and metastasis. J Cell Mol Med 2011; 15: 1887-95.
47. Feng L, Xie Y, Zhang H, Wu Y. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 2011; DOI: [Epub ahead of print].
48. Fish JE, Santoro MM, Morton SUet al.miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008; 15: 272-84.
49. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010; 464: 1196-200.
50. Wang S, Aurora AB, Johnson BAet al.The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-71.
51. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosom Cancer 2008; 47: 939-46.
52. Zhang J, Du YY, Lin YFet al.The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008; 377: 136-40.
53. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS ONE 2011; 6: e16617.
54. Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 2006; 6: 593-602.
55. Feng R, Chen X, Yu Yet al.miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010; 298: 50-63.
56. Guo J, Yao F, Lou Yet al.Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR. J Clin Gastroenterol 2007; 41: 783-8.
57. Koga T, Tokunaga E, Sumiyoshi Yet al.Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology 2008; 55: 1131-5.
58. Chen X, Ba Y, Ma Let al.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
59. Nelson KM, Weiss GJ. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 2008; 7: 3655-60.
60. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9.
61. Mitchell PS, Parkin RK, Kroh EMet al.Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-8.
62. Hanke M, Hoefig K, Merz Het al.A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010; 28: 655-61.
63. Michael A, Bajracharya SD, Yuen PSet al.Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 2010; 16: 34-8.
64. Park NJ, Zhou H, Elashoff Det al.Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009; 15: 5473-7.
65. Tanaka M, Oikawa K, Takanashi Met al.Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 2009; 4: e5532.
66. Tsujiura M, Ichikawa D, Komatsu Set al.Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-9.
67. Lawrie CH, Gal S, Dunlop HMet al.Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-5.
68. Ng EK, Chong WW, Jin Het al.Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-81.
69. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-9.
70. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-92.
71. Chim SS, Shing TK, Hung ECet al.Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008; 54: 482-90.
72. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 2009; 4: e6229.
73. Zhou H, Guo JM, Lou YRet al.Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 2010; 88: 709-17.
74. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-45.